Quantcast
New Genetic Map Of Autoimmune Variants

New Genetic Map Of Autoimmune Variants

Brett Smith for redOrbit.com - Your Universe Online Genetic mutations are thought to drive many autoimmune diseases in humans and a large international team of researchers has just identified 21 genetic variants that directly connect to...

Latest autoimmune diseases Stories

2014-10-31 08:24:59

PINEHURST, N.C., Oct. 31, 2014 /PRNewswire-iReach/ -- Assisi Animal Health, developers of the Assisi Loop(TM), a non-invasive and non-pharmaceutical healing and pain-management device for dogs, cats, horses and other animals, provides information to pet owners about how to treat inflammatory bowel disease (IBD) in dogs. Any dog breed can have IBD, but German shepherds, soft-coated wheaten terriers, shar-peis and basenjis are particularly prone. Logo -...

2014-10-30 12:28:18

2014 Distinguished Innovators Awards Recruit Immunology Leaders into Lupus Field to Find Root Causes that Can Propel New Treatments and a Cure NEW YORK, Oct. 30, 2014 /PRNewswire/ -- The Lupus Research Institute (LRI) announced recipients of its 2014 Distinguished Innovator Awards with three cutting-edge projects that tackle the underlying causes of the disease. The world's largest private grants in novel lupus research, the LRI Distinguished Innovator Awards support major studies...

2014-10-29 12:30:01

New endurance program unites psoriatic disease community and cycling enthusiasts to find a cure PORTLAND, Ore., Oct. 29, 2014 /PRNewswire-USNewswire/ -- Cyclists with psoriasis and psoriatic arthritis and the people who love them now have a new way to find a cure with the National Psoriasis Foundation Team NPF Cycle program, launching today on World Psoriasis Day. National Psoriasis Foundation Team NPF Cycle, presented by Novartis Pharmaceuticals Corporation, is an endurance...

2014-10-29 08:32:05

FREIBURG and HEIDELBERG, Germany, October 29, 2014 /PRNewswire/ -- Positive FDA feedback on the protocol for the US Phase III trial with LT-02, a key element of the product's global development program Lipid Therapeutics today announces that its European co-development partner Dr. Falk Pharma GmbH has enrolled the first patients into a pivotal Phase III trial with LT-02, a novel barrier function therapy for mild-moderately active ulcerative...

2014-10-28 16:27:34

Focusing development on rare autoimmune disorder IgG4-related disease (IgG4-RD) MONROVIA, Calif., Oct. 28, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced that it has regained all development and commercial rights to XmAb(®)5871 by seeking and obtaining a termination of the prior option and...

2014-10-28 08:37:02

TARRYTOWN, N.Y., Oct. 28, 2014 /PRNewswire/ -- Araim Pharmaceuticals, a privately held company engaged in developing novel treatments for devastating injuries and chronic diseases underserved by current therapies, today announced a Fast Track Designation from the FDA for its lead compound ARA290, for treatment of Sarcoidosis-associated Small Fiber Neuropathy (SFN). http://photos.prnewswire.com/prnvar/20141023/154567LOGO Small nerve fiber loss and damage causes autonomic and sensory...

2014-10-27 20:22:39

LA JOLLA, Calif., and JUPITER, Fla., Oct. 27, 2014 /PRNewswire-USNewswire/ -- Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute (TSRI). According to results released today from a Phase 2 study of 199 patients with active, moderate to severe disease, the drug candidate RPC1063 has potential to significantly improve the treatment paradigm for ulcerative colitis patients....

2014-10-27 08:28:51

"Get Your Full Course" addresses diet and nutritional considerations related to inflammatory bowel diseases and highlights Sunny's personal story of living with ulcerative colitis HORSHAM, Pa., Oct. 27, 2014 /PRNewswire/ -- Janssen Biotech, Inc. and the Crohn's & Colitis Foundation of America (CCFA) announced today the launch of Get Your Full Course, an educational campaign designed to provide resources for people living with inflammatory bowel diseases (IBD) on the paired role...

2014-10-23 23:12:12

Zion Health announces New Anti-Itch cream formulated to relieve itching from skin rash, bug bites, and irritated skin-Now available at Berkeley Bowl Health Food store in CA. San Francisco, CA (PRWEB) October 23, 2014 Zion Health announces Berkeley Bowl, a much-loved local supermarket in the East Bay, will now be carrying a new natural remedy for irritated skin; Ancient Clay Repair cream. This natural skin rash cream is the latest organic body care product offered by San Francisco-based...

2014-10-22 12:30:14

Presentations examine certain demographic and clinical disease characteristics that may be indicative of Cimzia® treatment response and remission for moderate to severe Crohn's disease ATLANTA, Oct. 22, 2014 /PRNewswire/ -- UCB, a global biopharmaceutical company focusing on CNS and immunology treatment and research, is sponsoring several data presentations on Cimzia(®) (certolizumab pegol) at the American College of Gastroenterology's (ACG) 2014 Annual Scientific Meeting in Philadelphia,...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related